acute myeloid leukemia
Showing NaN - NaN of 77
Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +13 more
-
Birmingham, Alabama
- +187 more
Apr 28, 2022
Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)
Recruiting
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- +3 more
-
Gilbert, Arizona
- +14 more
Apr 20, 2022
Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)
Active, not recruiting
- Acute Myeloid Leukemia
- Uproleselan
- Placebo
-
La Jolla, California
- +69 more
Apr 5, 2022
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Active, not recruiting
- Acute Myeloid Leukemia
- +13 more
- Azacitidine
- Gemtuzumab Ozogamicin
-
Burbank, California
- +176 more
Mar 25, 2022
Acute Myeloid Leukemia Trial in Australia, Germany, United States (AMG 673)
Terminated
- Acute Myeloid Leukemia
- AMG 673
-
Birmingham, Alabama
- +6 more
Mar 17, 2022
Acute Myeloid Leukemia Trial in Worldwide (Pracinostat, Placebos, Azacitidine)
Acute Myeloid Leukemia, Relapsed Adult AML Trial in United States (Lintuzumab-Ac225, Venetoclax, Spironolactone)
Recruiting
- Acute Myeloid Leukemia
- Relapsed Adult AML
- Lintuzumab-Ac225
- +2 more
-
Los Angeles, California
- +4 more
Feb 22, 2022
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)
Completed
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 23, 2022
Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional
Active, not recruiting
- Acute Myeloid Leukemia
- +8 more
- Iomab-B
- +2 more
-
Gilbert, Arizona
- +23 more
Feb 22, 2022
Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,
Terminated
- Acute Myeloid Leukemia
- +4 more
- Aldesleukin
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 15, 2021
Acute Myeloid Leukemia Trial in United States (AMV564, AMV564 in combination with pembrolizumab)
Completed
- Acute Myeloid Leukemia
- AMV564
- AMV564 in combination with pembrolizumab
-
San Francisco, California
- +9 more
Oct 11, 2021
Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)
Completed
- Hematologic Malignancy
- +4 more
-
Washington, District of Columbia
- +12 more
Jul 20, 2021
Acute Myeloid Leukemia Trial in Seattle (Telephone-Based Intervention, Behavioral, Psychological or Informational Intervention,
Terminated
- Acute Myeloid Leukemia
- Telephone-Based Intervention
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 18, 2021
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United
Completed
- Acute Myeloid Leukemia
- +27 more
- Caspofungin Acetate
- +2 more
-
Birmingham, Alabama
- +178 more
Mar 26, 2021
Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)
Completed
- Acute Myeloid Leukemia
- Midostaurin
- Standard of Care
-
La Jolla, California
- +18 more
Mar 12, 2021
Acute Myeloid Leukemia, Minimal Residual Disease Negativity Trial in Seattle (procedure, drug, other)
Withdrawn
- Acute Myeloid Leukemia
- Minimal Residual Disease Negativity
- Autologous Hematopoietic Stem Cell Transplantation
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 27, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,
Completed
- Acute Myeloid Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, Minnesota
- +1 more
Sep 9, 2020
Acute Myeloid Leukemia Trial in Aurora, New Orleans, Seattle (procedure, drug, other, radiation)
Completed
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Aurora, Colorado
- +3 more
Apr 3, 2020
Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in United States (ADCT-301)
Terminated
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
-
Atlanta, Georgia
- +10 more
Feb 12, 2020